Index of reports
> Cases with Pyrexia (183)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 183 Next >>
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-08-27
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Pneumonia, Cholecystitis Acute, Pyrexia, Enterocolitis, Herpes Zoster
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Inc424
Dosage: 30 mg, bid
Administration route: Oral
Indication: Myelofibrosis
Start date: 2011-12-12
End date: 2012-03-31
Inc424
Dosage: unk
Administration route: Oral
Start date: 2012-04-02
End date: 2012-04-09
Inc424
Dosage: 20 mg, qd
Start date: 2012-05-25
End date: 2012-08-18
Prednisolone
Dosage: 10 mg, qd
Administration route: Oral
Indication: Platelet Count Decreased
Start date: 2004-05-18
Other drugs received by patient: Lasix; MS Contin; Acetaminophen; Merislon; Lansoprazole; Exjade; Pursennid; Terranas; Amoban; Acetaminophen; Maxalt; Alosenn; Laxoberon; Celecoxib; Lyrica; Exjade; Morphine; Halcion; Magnesium Oxide; Vitamin B12; Uloric
Possible Prednisolone side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-26
Patient: 72 year old male
Reactions: Productive Cough, Optic Atrophy, Blood Creatine Phosphokinase Increased, Pneumonia, Normal Tension Glaucoma, Muscular Weakness, Pyrexia, Polymyositis, Aldolase Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Azathioprine Sodium
Dosage: 50 mg, unk
Indication: Polymyositis
Start date: 2007-10-01
Cyclosporine
Dosage: 200 mg, qd
Start date: 2007-11-01
Cyclosporine
Dosage: 150 mg, qd
Indication: Polymyositis
Start date: 2007-05-01
Cyclosporine
Dosage: 175 mg, qd
Prednisolone
Dosage: 6 mg, unk
Administration route: Oral
Start date: 2008-02-02
Prednisolone
Dosage: 10 mg, unk
Administration route: Oral
Indication: Polymyositis
Start date: 2007-05-01
Possible Prednisolone side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 72 year old male
Reactions: Optic Atrophy, Productive Cough, Blood Creatine Phosphokinase Increased, Pneumonia, Normal Tension Glaucoma, Muscular Weakness, Pyrexia, Polymyositis, Aldolase Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Azathioprine Sodium
Dosage: 50 mg, unk
Indication: Polymyositis
Start date: 2007-10-01
Cyclosporine
Dosage: 200 mg, qd
Start date: 2007-11-01
Cyclosporine
Dosage: 150 mg, qd
Indication: Polymyositis
Start date: 2007-05-01
Cyclosporine
Dosage: 175 mg, qd
Prednisolone
Dosage: 6 mg, unk
Administration route: Oral
Start date: 2008-02-02
Prednisolone
Dosage: 10 mg, unk
Administration route: Oral
Indication: Polymyositis
Start date: 2007-05-01
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-23
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s
Cyclophosphamide
Cyclophosphamide
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride
Etoposide
Etoposide
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Vincristine
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-08-23
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Renal Impairment, C-Reactive Protein Increased, Neoplasm Malignant, Neoplasm Progression, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2012-01-06
End date: 2012-01-09
Afinitor
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-12-14
End date: 2011-12-29
Afinitor
Dosage: 10 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-20
End date: 2011-10-03
Etodolac
Dosage: 400 mg, daily
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Prednisolone
Dosage: 5 mg
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-21
End date: 2011-09-01
Zometa
Dosage: unk ukn, unk
Indication: Metastatic Renal Cell Carcinoma
Start date: 2011-06-27
Other drugs received by patient: Allopurinol; Benidipine Hydrochloride; Vitamin B12; Limaprost Alfadex; Lansoprazole; Limaprost Alfadex; Flivas; Acetaminophen
Possible Prednisolone side effects in male
Reported by a physician from United Kingdom on 2012-08-21
Patient: male
Reactions: Pelvic Pain, Pyrexia, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Hepatosplenic T-Cell Lymphoma, Crohn's Disease, Sepsis, Platelet Count Decreased, Diabetic Ketoacidosis, Neutropenia, Rectal Discharge, Leukopenia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Azathioprine Sodium
Dosage: 2.5 mg/kg
Indication: Crohn's Disease
Azathioprine Sodium
Start date: 2002-01-01
End date: 2006-09-01
Azathioprine Sodium
Start date: 2001-06-01
Mercaptopurine
Indication: Crohn's Disease
Prednisolone
Indication: Product Used FOR Unknown Indication
Remicade
Indication: Crohn's Disease
End date: 2005-09-29
Remicade
Dosage: stopped in february - march (3rd infusion)
End date: 2006-02-01
Other drugs received by patient: Metronidazole; Vitamin B-12
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-08-20
Patient: female, weighing 47.7 kg (104.9 pounds)
Reactions: Cardio-Respiratory Arrest, Metabolic Acidosis, Hepatic Function Abnormal, Arthralgia, Disseminated Intravascular Coagulation, Platelet Count Decreased, Pyrexia, Device Related Infection, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Remicade
Indication: Rheumatoid Arthritis
Start date: 2011-12-06
Remicade
Start date: 2010-09-03
Remicade
Dosage: 20th dose
Start date: 2012-06-01
Remicade
Start date: 2009-08-21
Other drugs received by patient: Folic Acid; Edirol; Lansoprazole; Cefazolin Sodium; Warfarin Sodium
Possible Prednisolone side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-17
Patient: male
Reactions: Pneumonia, Viral Infection, Diabetes Mellitus, Pyrexia, C-Reactive Protein Decreased, Eosinophil Count Increased, Glycosylated Haemoglobin Increased, Haematocrit Decreased, Heart Rate Decreased, Respiratory Failure, Blood Glucose Increased, White Blood Cell Count Increased, Influenza
Drug(s) suspected as cause:
Clozaril
Dosage: 25 mg
Administration route: Oral
Start date: 2011-02-02
End date: 2011-02-04
Clozaril
Dosage: 50 mg
Administration route: Oral
Start date: 2011-02-05
End date: 2011-02-08
Clozaril
Dosage: 125 mg
Administration route: Oral
Start date: 2011-05-01
End date: 2011-05-04
Clozaril
Dosage: 225 mg
Administration route: Oral
Start date: 2011-05-19
End date: 2011-06-01
Clozaril
Dosage: 75 mg
Administration route: Oral
Start date: 2011-03-09
End date: 2011-03-15
Clozaril
Dosage: 100 mg
Administration route: Oral
Start date: 2011-04-28
End date: 2011-04-30
Clozaril
Dosage: 300 mg
Administration route: Oral
Start date: 2011-06-17
Clozaril
Dosage: 200 mg
Administration route: Oral
Start date: 2011-05-14
End date: 2011-05-18
Clozaril
Dosage: 75 mg
Start date: 2011-02-09
End date: 2011-02-15
Clozaril
Dosage: 100 mg
Administration route: Oral
Start date: 2011-02-16
End date: 2011-02-22
Clozaril
Dosage: 50 mg
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-08
Clozaril
Dosage: 100 mg
Administration route: Oral
Start date: 2011-03-16
End date: 2011-03-22
Clozaril
Dosage: 12.5 mg
Administration route: Oral
Start date: 2011-04-21
End date: 2011-04-21
Clozaril
Dosage: 175 mg
Administration route: Oral
Start date: 2011-05-09
End date: 2011-05-13
Clozaril
Dosage: 25 mg, unk
Start date: 2011-04-22
End date: 2011-04-23
Clozaril
Dosage: 250 mg
Administration route: Oral
Start date: 2011-06-02
End date: 2011-06-08
Clozaril
Dosage: 275 mg
Administration route: Oral
Start date: 2011-06-09
End date: 2011-06-16
Clozaril
Dosage: 50 mg
Administration route: Oral
Start date: 2011-04-24
End date: 2011-04-24
Clozaril
Dosage: 12.5 mg,
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-02-01
End date: 2011-02-01
Clozaril
Dosage: 75 mg
Administration route: Oral
Start date: 2011-04-25
End date: 2011-04-27
Clozaril
Dosage: 150 mg
Administration route: Oral
Start date: 2011-05-05
End date: 2011-05-08
Prednisolone
Dosage: 15 mg, qd
Start date: 2011-02-22
End date: 2011-02-28
Prednisolone
Dosage: 5 mg, daily
Start date: 2011-03-08
End date: 2011-03-14
Prednisolone
Dosage: 10 mg, unk
Start date: 2011-03-01
End date: 2011-03-07
Other drugs received by patient: Rhubarb; Invega; Nitrazepam; Biperiden Hydrochloride TAB; Sitagliptin Phosphate; Loxoprofen; Risperdal; Tamiflu; Invega; Lithium Carbonate; Lorazepam; Ronfleman; Risperdal; Flunitrazepam; Sodium Picosulfate; Ronfleman; Ronfleman; Ronfleman; Zithromax; Verapamil HCL; Invega; Biperiden Hydrochloride TAB; Sitagliptin Phosphate; Lorazepam; Loxoprofen; Risperdal; Rhubarb; Valproate Sodium
Possible Prednisolone side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-16
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Pneumonia, Cholecystitis Acute, Pyrexia, Herpes Zoster
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Inc424
Dosage: unk
Administration route: Oral
Start date: 2012-04-02
End date: 2012-04-09
Inc424
Dosage: 20 mg, qd
Start date: 2012-05-25
Inc424
Dosage: 30 mg, bid
Administration route: Oral
Indication: Myelofibrosis
Start date: 2011-12-12
End date: 2012-03-31
Prednisolone
Dosage: 10 mg, qd
Administration route: Oral
Indication: Platelet Count Decreased
Start date: 2004-05-18
Other drugs received by patient: Exjade; Vitamin B12; Halcion; Lansoprazole; Lasix; Celecoxib; Alosenn; Terranas; MS Contin; Maxalt; Amoban; Exjade; Acetaminophen; Uloric; Merislon; Magnesium Oxide; Pursennid; Laxoberon; Morphine; Acetaminophen; Lyrica
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-08-14
Patient: male, weighing 43.0 kg (94.6 pounds)
Reactions: Pneumonia Aspiration, Urine Output Decreased, Pyrexia, Haemothorax, Cardio-Respiratory Arrest, Hypopnoea, Respiratory Failure, Decreased Immune Responsiveness, Pleural Infection, Depressed Level of Consciousness, Hypoxia, Blood Pressure Decreased, Cough, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Etanercept
Start date: 2011-02-15
Etanercept
Start date: 2011-03-19
End date: 2011-03-19
Etanercept
Start date: 2011-03-26
End date: 2011-03-26
Etanercept
Etanercept
Indication: Rheumatoid Arthritis
Start date: 2009-06-01
End date: 2009-10-01
Etanercept
Start date: 2011-04-02
End date: 2011-04-02
Humira
Indication: Rheumatoid Arthritis
Start date: 2011-04-15
End date: 2011-04-29
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2011-04-14
End date: 2011-04-21
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2011-03-24
End date: 2011-05-04
Possible Prednisolone side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 61 year old female
Reactions: Mucosal Inflammation, Nausea, Pyrexia, Diffuse Large B-Cell Lymphoma Recurrent, Oral Herpes
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Methotrexate
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-08-13
Patient: male, weighing 43.0 kg (94.6 pounds)
Reactions: Pneumonia Aspiration, Urine Output Decreased, Pyrexia, Haemothorax, Cardio-Respiratory Arrest, Decreased Immune Responsiveness, Hypopnoea, Respiratory Failure, Pleural Infection, Hypoxia, Depressed Level of Consciousness, Blood Pressure Decreased, Cough, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Etanercept
Etanercept
Start date: 2011-02-15
Etanercept
Start date: 2011-04-02
End date: 2011-04-02
Etanercept
Start date: 2011-03-19
End date: 2011-03-19
Etanercept
Indication: Rheumatoid Arthritis
Start date: 2009-06-01
End date: 2009-10-01
Etanercept
Start date: 2011-03-26
End date: 2011-03-26
Humira
Indication: Rheumatoid Arthritis
Start date: 2011-04-15
End date: 2011-04-29
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2011-04-14
End date: 2011-04-21
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2011-03-24
End date: 2011-05-04
Possible Prednisolone side effects in 40 year old female
Reported by a physician from Japan on 2012-08-10
Patient: 40 year old female
Reactions: Gastrointestinal Haemorrhage, Trigeminal Neuralgia, RED Blood Cell Abnormality, Disseminated Intravascular Coagulation, Pyrexia, Circulatory Collapse, Staphylococcal Bacteraemia, Melaena, Hepatitis Fulminant, Hepatosplenomegaly, White Blood Cell Count Increased, Plasmapheresis, Anaemia, Cardiac Valve Vegetation, Alanine Aminotransferase Increased, Thrombotic Thrombocytopenic Purpura, Convulsion, Haemodialysis, Haemoglobin Decreased, Renal Impairment, Oliguria, Aspartate Aminotransferase Increased, Blood Smear Test Abnormal, Platelet Count Decreased, Transfusion, Haemorrhagic Diathesis, Altered State of Consciousness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: unk
Start date: 2007-10-01
End date: 2009-10-28
Tracleer
Dosage: 62.5 mg, bid
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2008-07-10
End date: 2009-09-30
Tracleer
Dosage: 62.5 mg, qd
Administration route: Oral
Start date: 2008-07-02
End date: 2008-07-09
Other drugs received by patient: Beraprost Sodium; Sarpogrelate Hydrochloride; Carbocisteine; Meloxicam; Trimebutine Maleate; Omeprazole
Possible Prednisolone side effects in 40 year old female
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-08-07
Patient: 40 year old female
Reactions: Thrombosis, Blood Creatine Phosphokinase Increased, Enterococcal Infection, Pyrexia, Decubitus Ulcer, Skin Ulcer, Systemic Sclerosis, Enterobacter Test Positive, White Blood Cell Count Decreased, FAT Necrosis, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Haemoglobin Decreased, Overlap Syndrome, Arthralgia, Aspartate Aminotransferase Increased, Systemic Lupus Erythematosus, Swelling, Platelet Count Decreased, Necrotising Fasciitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Azathioprine
Indication: Overlap Syndrome
Azathioprine
Indication: Systemic Lupus Erythematosus
Hydroxychloroquine Sulfate
Indication: Systemic Lupus Erythematosus
Hydroxychloroquine Sulfate
Indication: Overlap Syndrome
Prednisolone
Dosage: 10 mg,
Indication: Overlap Syndrome
Prednisolone
Dosage: 10 mg,
Indication: Systemic Lupus Erythematosus
Possible Prednisolone side effects in 56 year old female
Reported by a pharmacist from Japan on 2012-08-03
Patient: 56 year old female
Reactions: Flushing, Drug Eruption, Malaise, Diabetes Mellitus, Hypertrophy, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adrenocortical Hormone
Administration route: Topical
Indication: Drug Eruption
Antihistamines
Indication: Drug Eruption
Darunavir Ethanolate
Administration route: Oral
Indication: HIV Infection
Emtricitabine / Tenofovir Disoproxil Fumarate
Administration route: Oral
Indication: HIV Infection
Prednisolone
Administration route: Oral
Prednisolone
Administration route: Oral
Indication: Drug Eruption
Prezista
Administration route: Oral
Indication: Antiretroviral Therapy
Ritonavir
Indication: HIV Infection
Sulfamethoxazole and Trimethoprim
Indication: Antifungal Prophylaxis
Possible Prednisolone side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: 82 year old female
Reactions: Confusional State, Pyrexia, Lymphoma
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Mabthera
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Methotrexate
Possible Prednisolone side effects in 77 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 77 year old male
Reactions: Abscess Fungal, Candida Sepsis, Pyrexia, Loss of Consciousness, Pseudomonal Sepsis, Pleural Effusion, Tachypnoea, Oedema, Thrombocytopenia, Anaemia, Pseudomonas Infection, Pancytopenia, Staphylococcal Sepsis, Ascites, Staphylococcal Infection, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ceftazidime
Indication: Staphylococcal Infection
Ceftazidime
Indication: Pseudomonas Infection
Imipenem and Cilastatin
Indication: Pseudomonas Infection
Imipenem and Cilastatin
Indication: Staphylococcal Infection
Isepamicin
Prednisolone
Dosage: 50 mg, unk
Indication: Pemphigus
Teicoplanin
Indication: Pseudomonas Infection
Teicoplanin
Indication: Staphylococcal Infection
Possible Prednisolone side effects in 37 year old male
Reported by a health professional (non-physician/pharmacist) from Iran (Islamic Republic OF) on 2012-07-19
Patient: 37 year old male
Reactions: Renal Impairment, Viral Infection, Pyrexia, Renal Pain, Blood Creatinine Increased
Drug(s) suspected as cause:
Azathioprine
Indication: Renal Transplant
Cyclosporine
Indication: Renal Transplant
Methylprednisolone
Dosage: 2 courses of methylprednisolone pulses within three weeks
Indication: Renal Transplant
Mycophenolate Mofetil
Indication: Renal Transplant
Prednisolone
Indication: Renal Transplant
Possible Prednisolone side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: 60 year old female
Reactions: Drug Resistance, Blood Creatine Phosphokinase Increased, Arthralgia, Disease Recurrence, Hypoxia, Atypical Mycobacterial Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclosporine
Dosage: 50 mg, unk
Administration route: Oral
Indication: Dermatomyositis
Cyclosporine
Dosage: 50 mg, unk
Administration route: Oral
Prednisolone
Dosage: 60 mg, unk
Administration route: Oral
Indication: Dermatomyositis
Prednisolone
Dosage: 12 mg, unk
Administration route: Oral
Prednisolone
Dosage: 15 mg, unk
Administration route: Oral
Prednisolone
Dosage: 40 mg, unk
Administration route: Oral
Prednisolone
Dosage: 45 mg, unk
Administration route: Oral
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Prednisolone side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18
Patient: 60 year old female
Reactions: Blood Creatine Phosphokinase Increased, Drug Resistance, Arthralgia, Disease Recurrence, Atypical Mycobacterial Infection, Hypoxia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclosporine
Dosage: 50 mg, unk
Administration route: Oral
Indication: Dermatomyositis
Cyclosporine
Dosage: 50 mg, unk
Administration route: Oral
Prednisolone
Dosage: 45 mg, unk
Administration route: Oral
Prednisolone
Dosage: 40 mg, unk
Administration route: Oral
Prednisolone
Dosage: 60 mg, unk
Administration route: Oral
Indication: Dermatomyositis
Prednisolone
Dosage: 12 mg, unk
Administration route: Oral
Prednisolone
Dosage: 15 mg, unk
Administration route: Oral
Possible Prednisolone side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-17
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Pneumonia, Cholecystitis Acute, Pyrexia, Herpes Zoster
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Inc424
Dosage: unk
Administration route: Oral
Start date: 2012-04-02
End date: 2012-04-09
Inc424
Dosage: 20 mg, qd
Start date: 2012-05-25
Inc424
Dosage: 30 mg, bid
Administration route: Oral
Indication: Myelofibrosis
Start date: 2011-12-12
End date: 2012-03-31
Prednisolone
Dosage: 10 mg, qd
Administration route: Oral
Indication: Platelet Count Decreased
Start date: 2004-05-18
Other drugs received by patient: Halcion; Lyrica; Pursennid; Amoban; Lasix; Morphine; Magnesium Oxide; Exjade; Lansoprazole; Acetaminophen; Vitamin B12; Celecoxib; MS Contin; Acetaminophen
Possible Prednisolone side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-07-13
Patient: female
Reactions: Gastrointestinal Haemorrhage, Trigeminal Neuralgia, RED Blood Cell Abnormality, Disseminated Intravascular Coagulation, Pyrexia, Circulatory Collapse, Staphylococcal Bacteraemia, Melaena, White Blood Cell Count Increased, Hepatitis Fulminant, Hepatosplenomegaly, Mechanical Ventilation, Alanine Aminotransferase Increased, Plasmapheresis, Anaemia, Thrombotic Thrombocytopenic Purpura, Convulsion, Haemodialysis, Haemoglobin Decreased, Renal Impairment, Oliguria, Aspartate Aminotransferase Increased, Blood Smear Test Abnormal, Transfusion, Haemorrhagic Diathesis, Platelet Count Decreased, Altered State of Consciousness, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: unk
Start date: 2007-10-01
End date: 2009-10-28
Tracleer
Dosage: 62.5 mg, bid
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2008-07-10
End date: 2009-09-30
Tracleer
Dosage: 62.5 mg, qd
Administration route: Oral
Start date: 2008-07-02
End date: 2008-07-09
Other drugs received by patient: Carbocisteine; Omeprazole; Sarpogrelate Hydrochloride; Beraprost Sodium; Meloxicam; Trimebutine Maleate
Possible Prednisolone side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Possible Prednisolone side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-10
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Cholecystitis Acute, Pyrexia, Herpes Zoster
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Inc424
Dosage: unk
Administration route: Oral
Start date: 2012-04-02
End date: 2012-04-09
Inc424
Dosage: 30 mg, bid
Administration route: Oral
Indication: Myelofibrosis
Start date: 2011-12-12
End date: 2012-03-31
Inc424
Dosage: 20 mg, qd
Start date: 2012-05-25
Prednisolone
Dosage: 10 mg, qd
Administration route: Oral
Indication: Platelet Count Decreased
Start date: 2004-05-18
Other drugs received by patient: Lansoprazole; Celecoxib; Lasix; Vitamin B12; Magnesium Oxide; Exjade; Morphine; MS Contin; Halcion
Possible Prednisolone side effects in 50 year old female
Reported by a physician from Portugal on 2012-07-10
Patient: 50 year old female
Reactions: Weight Decreased, Biliary Cirrhosis Primary, Steatorrhoea, Wrist Fracture, Ganglioneuroma, Cholestasis, Pyrexia, Multiple Fractures, Hepatic Steatosis, Chest Pain, Sjogren's Syndrome, RIB Fracture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adalimumab
Indication: Rheumatoid Arthritis
Alendronate Sodium
Indication: Rheumatoid Arthritis
Start date: 2003-01-01
Azathioprine
Dosage: frequency: everyday (qd)
Indication: Rheumatoid Arthritis
Start date: 1997-12-01
End date: 2004-06-01
Azulfidine
Dosage: frequency: everyday (qd)
Indication: Rheumatoid Arthritis
Etanercept
Indication: Rheumatoid Arthritis
Methotrexate
Methotrexate
Indication: Rheumatoid Arthritis
Start date: 1995-09-01
End date: 1997-09-01
Methotrexate
Methotrexate
Start date: 1996-11-01
End date: 1997-01-01
Prednisolone
Dosage: frequency: everyday (qd). dose reported: 5 mg qd} 10 mg qd
Indication: Rheumatoid Arthritis
Prednisolone
Dosage: frequency: everyday (qd)
Rituximab
Indication: Rheumatoid Arthritis
Rituximab
Other drugs received by patient: Hydroxychloroquine Sulfate; Hydroxychloroquine Sulfate
Page 1 Next >>
|